Mice Model Market Share, Size, Trends, Industry Analysis Report, By Model and Service; By End User; By Application (Neurology, Oncology, Cardiovascular Diseases, Genetic Diseases, Others); By Region; Segment Forecast, 2024 - 2032

Mice Model Market Share, Size, Trends, Industry Analysis Report, By Model and Service; By End User; By Application (Neurology, Oncology, Cardiovascular Diseases, Genetic Diseases, Others); By Region; Segment Forecast, 2024 - 2032

The global mice model market size is expected to reach USD 2.68 billion by 2032, according to a new study by Polaris Market Research. The report “Mice Model Market Share, Size, Trends, Industry Analysis Report, By Model and Service; By End User; By Application (Neurology, Oncology, Cardiovascular Diseases, Genetic Diseases, Others); By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mice model market is influenced by drug discovery and development efforts. Mice models, particularly genetically engineered strains, play vital roles in pharmaceutical research. They closely replicate human physiology and genetics, aiding in studying disease mechanisms, evaluating drug effectiveness, and assessing safety profiles. Through preclinical trials, these models help uncover pharmacokinetics, pharmacodynamics, and potential adverse effects of new drug candidates. Furthermore, mice models assist in identifying therapeutic targets and biomarkers, accelerating drug development processes. With substantial investments in research and development by pharmaceutical firms to address unmet medical needs, the demand for mice models is poised to grow, driving advancements in drug discovery and development.

Humanized mouse models for drug testing present significant opportunities in the mouse model market. Engineered to replicate human immune systems and physiology, these models offer more accurate representations of drug responses. By incorporating human cells or genes, researchers can better predict drug efficacy and safety. With the rising demand for personalized medicine, humanized mouse models are crucial for preclinical testing. They enable pharmaceutical companies to assess potential drug candidates more accurately, leading to higher success rates in clinical trials and reduced development costs.

Advancements in translational research are further driving growth in the mice model market. Translational research aims to bridge basic scientific discoveries with clinical applications, and mice models play a pivotal role. As researchers seek to understand and treat complex human diseases, demand for genetically engineered mice models that accurately mimic these diseases is increasing. These models enable the study of disease progression, treatment efficacy, and biomarker identification. Furthermore, breakthroughs in gene-editing technologies such as CRISPR/Cas9 have transformed the creation of genetically modified mice models, enhancing their precision and efficiency in disease modeling.

Emerging applications in regenerative medicine are creating new opportunities in the mice model market. Regenerative medicine aims to restore damaged tissues and organs using advanced therapies like stem cells and tissue engineering. Mice models play a crucial role in studying regenerative processes, evaluating novel treatments, and translating preclinical findings into clinical applications. These models enable research into stem cell therapies, tissue regeneration techniques, and biomaterial implants for various conditions. Additionally, humanized mice models containing human cells or tissues offer more accurate representations of human biology, further advancing regenerative medicine research.

Mice Model Market Report Highlights

In 2023, the model segment held a significant revenue share owing to versatile applications, customization options, and technological advancements.

In 2023, the pharmaceutical and biotechnology companies segment held a significant market revenue share owing to their applications in drug development and testing, disease modeling, and personalized medicine research.

In 2023, the oncology segment held a significant revenue share owing to the high prevalence of cancer globally, the rising trend of personalized medicine, and technological advancements.

North America dominated the global market in 2023 due to advanced research infrastructure, strong presence of pharmaceutical and biotechnology companies, and government funding and support.

The market is highly competitive owing to the existence of market players with a global presence, including Charles River Laboratories International, Inc., Cyagen Biosciences Inc., Envigo, genOway S.A., Harbour Biomed, Hera Biolabs, Inotiv, Janvier Labs, Ozgene Pty Ltd., PolyGene, Sage Labs, Taconic Biosciences, Inc., The Jackson Laboratory, Trans Genic Inc.

Polaris Market Research has segmented the Mice Model market report based on model and service, end user, application, and region:

Mice Model, Model and Service Outlook (Revenue - USD Billion, 2019 - 2032)

Model

Outbred Mice

Inbred Mice

Genetically Engineered Mice

Others

Service

Breeding

Genetic Testing

Cryopreservation

Rederivation

Others

Mice Model, End User Outlook (Revenue - USD Billion, 2019 - 2032)

Contract Research and Manufacturing Organizations

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Others

Mice Model, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Neurology

Oncology

Cardiovascular Diseases

Genetic Diseases

Others

Mice Model, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Malaysia

Indonesia

South Korea

Australia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa